# Ganot Capital

> Ganot Capital is a VC fund in Hollywood backing Health Care and Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Hollywood, United States
- Total investments: 3
- Last investment: Jun 2021
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/ganot-capital
- Website: http://www.ganotcapital.com

Ganot Capital is a VC fund in Hollywood focused on Health Care and Medical. Ganot is a privately held, family owned and operated, investment company that has over 50 years of healthcare investment experience. Ganot acquires and invests through buyouts, growth capital and venture capital. Ganot's portfolio spans across the senior care sector and includes real estate properties, healthcare service companies, medicaldevice companies and biopharmaceutical companies.

## Contacts

5 contacts available for Ganot Capital. Shizune tracks 1 team members at Ganot Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ganot-cap?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Medical | 1 | 33% |
| Biotechnology | 1 | 33% |
| Medical Device | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Series C | 1 | 33% |
| Series D | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 1 | 33% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Guy Katsav | Managing Director, Healthcare Investments | 2 | https://shizune.co/investors/profile/guy-katsav-9f7e |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Notal Vision | Notal Vision is diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. | $60M | Series D | Jun 01, 2021 |  |
| Azura Ophthalmics | Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S. | $20M | Series C | Oct 22, 2020 |  |
| Azura Ophthalmics | Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S. | $16M | Series B | Oct 10, 2017 |  |

3 of 3 investments shown.

## Co-investors
- [Medical Research Commercialisation Fund (MRCF)](https://shizune.co/investors/profile/medical-research-commercialisation-fund-mrcf) — VC Fund, 2 deals together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 2 deals together
- [TPG Biotech](https://shizune.co/investors/profile/tpg-biotech) — VC Fund, 2 deals together
- [Brandon Capital](https://shizune.co/investors/profile/brandon-capital-partners) — VC Fund, 1 deal together
- [Elron Ventures](https://shizune.co/investors/profile/elron-electronic-industries) — VC Fund, 1 deal together
- [Evergreen Venture Partners](https://shizune.co/investors/profile/evergreen-venture-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Ganot Capital invest in?

Ganot Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series B and Series C stage. Most of the 3 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ganot Capital?

Public channels for Ganot Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ganot Capital?

The team at Ganot Capital includes Guy Katsav (Managing Director, Healthcare Investments). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co